In this review, we will examine the ongoing challenges of glioblastoma treatment and identify immunotherapeutic approaches that could treat glioblastoma, including Isocitrate dehydrogenase (IDH), Epidermal Growth Factor Receptor (EGFR), and Telomerase reverse transcriptase (TERT) peptide vaccines. This evidence concerns the gene EGFR and glioblastoma.